Stoke Therapeutics
Stock Forecast, Prediction & Price Target
Stoke Therapeutics Financial Estimates
Stoke Therapeutics Revenue Estimates
Stoke Therapeutics EBITDA Estimates
Stoke Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $12.40M 0% | $8.78M -29.22% | Avg: $16.31M Low: $12.77M High: $22.33M avg. 85.86% | Avg: $26.18M Low: $17.74M High: $32.55M avg. 60.48% | Avg: $81.65M Low: $55.32M High: $101.50M avg. 211.78% | Avg: $159.81M Low: $108.27M High: $198.66M avg. 95.71% |
Net Income
% change YoY
| $-84.71M N/A | $-93.11M -9.91% | $-104.69M -12.44% | Avg: $-143.27M Low: $-150.90M High: $-99.86M avg. -36.84% | Avg: $-153.53M Low: $-125.00M High: $-84.91M avg. -7.16% | Avg: $-78.31M Low: $-103.05M High: $-45.48M avg. 48.99% | Avg: $-36.07M Low: $-47.47M High: $-20.95M avg. 53.93% |
EBITDA
% change YoY
| $-86.06M N/A | $-104.35M -21.25% | $-112.30M -7.61% | Avg: $3.26M Low: $2.55M High: $4.46M avg. 102.90% | Avg: $5.23M Low: $3.54M High: $6.51M avg. 60.48% | Avg: $16.33M Low: $11.06M High: $20.30M avg. 211.78% | Avg: $31.96M Low: $21.65M High: $39.73M avg. 95.71% |
EPS
% change YoY
| -$2.31 N/A | -$2.39 -3.46% | -$2.38 0.41% | Avg: -$2.61 Low: -$3.43 High: -$2.27 avg. -9.63% | Avg: -$2.43 Low: -$2.84 High: -$1.93 avg. 6.86% | Avg: -$1.78 Low: -$2.34 High: -$1.03 avg. 26.75% | Avg: -$0.82 Low: -$1.08 High: -$0.48 avg. 53.93% |
Operating Expenses
% change YoY
| $86.06M N/A | $116.76M 35.66% | $123.55M 5.81% | Avg: $34.55M Low: $27.04M High: $47.28M avg. -72.03% | Avg: $55.45M Low: $37.57M High: $68.93M avg. 60.48% | Avg: $172.89M Low: $117.13M High: $214.92M avg. 211.78% | Avg: $338.37M Low: $229.25M High: $420.63M avg. 95.71% |
FAQ
What is Stoke Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.73% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -150.90M, average is -143.27M and high is -99.86M.
What is Stoke Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 113.46% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $12.77M, average is $16.31M and high is $22.33M.
What is Stoke Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.47% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.43, average is -$2.61 and high is $-2.27.
What is the best performing analyst?
In the last twelve months analysts have been covering Stoke Therapeutics stock. The most successful analyst is Marc Goodman.